News

RedHill Biopharma to Host First Quarter 2015 Financial Results Conference Call on April 30, 2015

RedHill Biopharma to Host First Quarter 2015 Financial Results Conference Call on April 30, 2015

Read More...

RedHill Biopharma Receives Notice of Allowance for Additional U.S. Patent for RHB-105 H. pylori Bacterial Infection Treatment

RedHill Biopharma Receives Notice of Allowance for Additional U.S. Patent for RHB-105 H. pylori Bacterial Infection Treatment   RedHill Biopharma Receives Notice of Allowance for Additional U.S. Patent for RHB-105 H. pylori Bacterial Infection Treatment – Hebrew

Read More...

RedHill Biopharma Acquires Phase II First-In-Class Oral Small Molecule SK2 Inhibitor from Apogee Biotech

RedHill Biopharma Acquires Phase II First-In-Class Oral Small Molecule SK2 Inhibitor from Apogee Biotech   RedHill Biopharma Acquires Phase II First-In-Class Oral Small Molecule SK2 Inhibitor from Apogee Biotech – Hebrew

Read More...

RedHill Biopharma to Present at the 3rd Annual Autoimmune & Inflammation Leaders’ Forum 2015

RedHill Biopharma to Present at the 3rd Annual Autoimmune & Inflammation Leaders’ Forum 2015

Read More...

RedHill Biopharma to Present at VirtualInvestorConferences.com Online Event on March 5, 2015

RedHill Biopharma to Present at VirtualInvestorConferences.com Online Event on March 5, 2015

Read More...

RedHill Biopharma to Present at Bio-Europe Spring 2015 International Partnering Conference

RedHill Biopharma to Present at Bio-Europe Spring 2015 International Partnering Conference

Read More...

RedHill Biopharma to Present at the 27th Annual ROTH Conference

RedHill Biopharma to Present at the 27th Annual ROTH Conference

Read More...

Positive Bioavailability Studies of RedHill’s BEKINDA™ to be Presented at the 2015 American Society for Clinical Pharmacology and Therapeutics (ASCPT) Meeting

Positive Bioavailability Studies of RedHill’s BEKINDA™ to be Presented at the 2015 American Society for Clinical Pharmacology and Therapeutics (ASCPT) Meeting   Positive Bioavailability Studies of RedHills BEKINDA™ to be Presented at the 2015 American Society for Clinical Pharmacology and Therapeutics (ASCPT) Meeting – Hebrew

Read More...

RedHill Biopharma Reports 2014 Fourth Quarter and Year-End Financial Results

RedHill Biopharma Reports 2014 Fourth Quarter and Year-End Financial Results   RedHill Biopharma Reports 2014 Fourth Quarter and Year-End Financial Results – Hebrew

Read More...

RedHill Biopharma to Host 2014 Fourth Quarter and Year-End Financial Results Conference Call on February 26 2015

RedHill Biopharma to Host 2014 Fourth Quarter and Year-End Financial Results Conference Call on February 26 2015

Read More...

News